Skip to content

Balchem BCPC Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

AVT
AvantorAVTR
$1.9M-26.9%
Darling Ingredients Inc. logo
Darling Ingredients Inc.DAR
$2.56M+649%
Perimeter Solutions logo
Perimeter SolutionsPRM
$3M+7,217%
Albemarle logo
AlbemarleALB
$8.92M+652%
Abbott logo
AbbottABT
$116M-59.6%
Merck & Co. logo
Merck & Co.MRK
$157M+726%

Other financials

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation

See full
Market cap$5.33B+0.5%
Enterprise value$5.3B+0.1%
P/E33.7×-5.1×
P/S-0.5×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp
FCF margin14.9%

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0.0×
Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Balchem's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Balchem's stock issuance proceeds?
Balchem (BCPC) reported stock issuance proceeds of $6.73M in Q1 2026.
How has Balchem's stock issuance proceeds changed year-over-year?
Balchem's stock issuance proceeds increased by 303.3% year-over-year, from $1.67M to $6.73M.
What is the long-term trend for Balchem's stock issuance proceeds?
Over 4 years (2021 to 2025), Balchem's stock issuance proceeds has grown at a 7.6% compound annual growth rate (CAGR), from $6.94M to $9.31M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.